Summary
- Current Price
- As of today, ALGS price is $7.97, up +2.97% on
- Current Price All-Time High
- ALGS price is currently -99.15% below its historical high of $937.75 set on
- Market Cap
- ALGS current market cap is $49M, up +5.81% over the past 365 days
- PE Ratio
- ALGS PE ratio is unknown
- Revenue
- ALGS current annual revenue is $2.19M, down -44.59% year-over-year
- Next Earnings
- The next earnings release for ALGS is on
Profile
| Metric | Value |
|---|---|
| Full Name | Aligos Therapeutics, Inc. |
| Ticker | NASDAQ: ALGS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | aligos.com |
| Employees | 70 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $7.97 | ||
| Price, 1D Change | +2.97% | |
| $49M | ||
| - | ||
| - | ||
| 2.01 | ||
| $2M | ||
| Revenue, 1Y Change | -44.59% | |
| -$2.45 | ||
| EPS, 1Y Change | +88.31% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:25 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$2.45 | ||
| EPS Estimate | N/A | -$6.53 |
| EPS Est. Change | N/A | -166.92% |
| $2.19M | ||
| Revenue Estimate | N/A | $2.13M |
| Revenue Est. Change | N/A | -2.79% |
| $7.97 | ||
| Price Target | - | $48.00 |
| Price Tgt. Change | - | +502.26% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$10.36 | -$20.94 | -102.17% | |
| -$7.59 | -$2.45 | +67.74% | |
| -$6.53 | N/A | -166.92% | |
| -$5.34 | N/A | -118.24% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $3.74M | $3.95M | +5.37% | |
| $2.45M | $2.19M | -10.66% | |
| $2.13M | N/A | -2.79% | |
| $2.23M | N/A | +1.78% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +5.15% | ||
| -63.52% | ||
| +5.81% | ||
| +30.68% | ||
| -44.59% | ||
| -84.28% | ||
| +88.31% | ||
| -100.00% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $7.97 | ||
| $8.68 | ||
| SMA 200 vs Price | +8.85% | |
| $7.28 | ||
| SMA 50 vs Price | -8.65% | |
| 2.01 | ||
| $0.60 | ||
| 60.14 | ||
| 89.48% | ||
| 95.71% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $2.19M | ||
| -$2.45 | ||
| $1.26M | ||
| 57.46% | ||
| -$87.99M | ||
| -4,024.93% | ||
| -$24.19M | ||
| -1,106.72% | ||
| -$87.06M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.10 | ||
| 3.90 | ||
| 3.90 | ||
| - | ||
| 2 | ||
| -11.61 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 22.44 | ||
| 0.92 | ||
| 0.27 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $53.55M | ||
| $77.95M | ||
| $89.58M | ||
| $82.86M | ||
| $36.04M | ||
| $21.23M | ||
| $5.25M | ||
| $3.73M | ||
| $3.98M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $26.38M | ||
| $89.24M | ||
| $930.00K | ||
| $20.72M | ||
| $930.00K | ||
| $0.00 | ||
| $314.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$82.50M | ||
| -$37.83M | ||
| $101.64M | ||
| $437.00K | ||
| -$82.94M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| WestPark Capital | ||
| HC Wainwright & Co. | → | |
| UBS | ||
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. |
Analyst sentiment
Institutional ownership
Screeners with ALGS
FAQ
What is the ticker symbol for Aligos Therapeutics, Inc.?
The ticker symbol for Aligos Therapeutics, Inc. is NASDAQ:ALGS
Does Aligos Therapeutics, Inc. pay dividends?
No, Aligos Therapeutics, Inc. does not pay dividends
What sector is Aligos Therapeutics, Inc. in?
Aligos Therapeutics, Inc. is in the Healthcare sector
What industry is Aligos Therapeutics, Inc. in?
Aligos Therapeutics, Inc. is in the Biotechnology industry
What country is Aligos Therapeutics, Inc. based in?
Aligos Therapeutics, Inc. is headquartered in United States
When did Aligos Therapeutics, Inc. go public?
Aligos Therapeutics, Inc. initial public offering (IPO) was on October 16, 2020
Is Aligos Therapeutics, Inc. in the S&P 500?
No, Aligos Therapeutics, Inc. is not included in the S&P 500 index
Is Aligos Therapeutics, Inc. in the NASDAQ 100?
No, Aligos Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Aligos Therapeutics, Inc. in the Dow Jones?
No, Aligos Therapeutics, Inc. is not included in the Dow Jones index
When was Aligos Therapeutics, Inc. last earnings report?
Aligos Therapeutics, Inc.'s most recent earnings report was on March 5, 2026
When does Aligos Therapeutics, Inc. report earnings?
The next expected earnings date for Aligos Therapeutics, Inc. is May 5, 2026
Data Sources & References
- ALGS Official Website www.aligos.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1799448/000119312526092614/0001193125-26-092614-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1799448/000119312526092614/0001193125-26-092614-index.htm
- ALGS Profile on Yahoo Finance finance.yahoo.com/quote/ALGS
- ALGS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/algs